Effect of Oral Furosemide on patients with preeclampsia during pregnancy

Phase 3

Recruiting

• Conditions: nspecified pre-eclampsia.; Unspecified pre-eclampsia; O14.9

• Registration Number: IRCT20230722058884N1
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 118

Inclusion Criteria

All patients who have had a recent pregnancy with preeclampsia

Exclusion Criteria

Age under 18
Patients with prior history of hypertension
Patients with renal disease
Patients with history of congenital heart defects

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of persistent hypertension in day 5 post partum. Timepoint: Day 5 post partum. Method of measurement: Manual sphygmomanometer.